BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16609024)

  • 1. Bead-based ELISA for validation of ovarian cancer early detection markers.
    Scholler N; Crawford M; Sato A; Drescher CW; O'Briant KC; Kiviat N; Anderson GL; Urban N
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2117-24. PubMed ID: 16609024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.
    Andersen MR; Goff BA; Lowe KA; Scholler N; Bergan L; Drescher CW; Paley P; Urban N
    Gynecol Oncol; 2010 Mar; 116(3):378-83. PubMed ID: 19945742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer.
    Yang WL; Lu Z; Guo J; Fellman BM; Ning J; Lu KH; Menon U; Kobayashi M; Hanash SM; Celestino J; Skates SJ; Bast RC
    Cancer; 2020 Feb; 126(4):725-736. PubMed ID: 31714597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort.
    Fortner RT; Schock H; Le Cornet C; Hüsing A; Vitonis AF; Johnson TS; Fichorova RN; Fashemi T; Yamamoto HS; Tjønneland A; Hansen L; Overvad K; Boutron-Ruault MC; Kvaskoff M; Severi G; Boeing H; Trichopoulou A; Papatesta EM; La Vecchia C; Palli D; Sieri S; Tumino R; Sacerdote C; Mattiello A; Onland-Moret NC; Peeters PH; Bueno-de-Mesquita HBA; Weiderpass E; Quirós JR; Duell EJ; Sánchez MJ; Navarro C; Ardanaz E; Larrañaga N; Nodin B; Jirström K; Idahl A; Lundin E; Khaw KT; Travis RC; Gunter M; Johansson M; Dossus L; Merritt MA; Riboli E; Terry KL; Cramer DW; Kaaks R
    Int J Cancer; 2018 Apr; 142(7):1355-1360. PubMed ID: 29159934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women.
    Autelitano DJ; Raineri L; Knight K; Bannister K; Rice GE
    J Transl Med; 2012 Mar; 10():45. PubMed ID: 22410202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study.
    Funston G; Hamilton W; Abel G; Crosbie EJ; Rous B; Walter FM
    PLoS Med; 2020 Oct; 17(10):e1003295. PubMed ID: 33112854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.
    Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P
    Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of serum miR-21, HE4 and CA125 in surveillance for postoperative recurrent or metastatic ovarian cancer.
    Gong Z; Han S; Zhang C; Zhao H; Xu J; Sun X
    Pak J Med Sci; 2022; 38(4Part-II):939-945. PubMed ID: 35634597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a Biomarker Panel and Longitudinal Biomarker Performance for Early Detection of Ovarian Cancer.
    Simmons AR; Clarke CH; Badgwell DB; Lu Z; Sokoll LJ; Lu KH; Zhang Z; Bast RC; Skates SJ
    Int J Gynecol Cancer; 2016 Jul; 26(6):1070-7. PubMed ID: 27206285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Prospective Evaluation of Early Detection Biomarkers for Ovarian Cancer in the European EPIC Cohort.
    Terry KL; Schock H; Fortner RT; Hüsing A; Fichorova RN; Yamamoto HS; Vitonis AF; Johnson T; Overvad K; Tjønneland A; Boutron-Ruault MC; Mesrine S; Severi G; Dossus L; Rinaldi S; Boeing H; Benetou V; Lagiou P; Trichopoulou A; Krogh V; Kuhn E; Panico S; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Gram IT; Weiderpass E; Duell EJ; Sanchez MJ; Ardanaz E; Etxezarreta N; Navarro C; Idahl A; Lundin E; Jirström K; Manjer J; Wareham NJ; Khaw KT; Byrne KS; Travis RC; Gunter MJ; Merritt MA; Riboli E; Cramer DW; Kaaks R
    Clin Cancer Res; 2016 Sep; 22(18):4664-75. PubMed ID: 27060155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
    Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC
    Br J Cancer; 2024 Mar; 130(5):861-868. PubMed ID: 38195887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.
    Mukama T; Fortner RT; Katzke V; Hynes LC; Petrera A; Hauck SM; Johnson T; Schulze M; Schiborn C; Rostgaard-Hansen AL; Tjønneland A; Overvad K; Pérez MJS; Crous-Bou M; Chirlaque MD; Amiano P; Ardanaz E; Watts EL; Travis RC; Sacerdote C; Grioni S; Masala G; Signoriello S; Tumino R; Gram IT; Sandanger TM; Sartor H; Lundin E; Idahl A; Heath AK; Dossus L; Weiderpass E; Kaaks R
    Br J Cancer; 2022 May; 126(9):1301-1309. PubMed ID: 35031764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort.
    Fortner RT; Vitonis AF; Schock H; Hüsing A; Johnson T; Fichorova RN; Fashemi T; Yamamoto HS; Tjønneland A; Hansen L; Overvad K; Boutron-Ruault MC; Kvaskoff M; Severi G; Boeing H; Trichopoulou A; Benetou V; La Vecchia C; Palli D; Sieri S; Tumino R; Matullo G; Mattiello A; Onland-Moret NC; Peeters PH; Weiderpass E; Gram IT; Jareid M; Quirós JR; Duell EJ; Sánchez MJ; Chirlaque MD; Ardanaz E; Larrañaga N; Nodin B; Brändstedt J; Idahl A; Khaw KT; Allen N; Gunter M; Johansson M; Dossus L; Merritt MA; Riboli E; Cramer DW; Kaaks R; Terry KL
    J Ovarian Res; 2017 Mar; 10(1):20. PubMed ID: 28320479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women.
    Gentry-Maharaj A; Blyuss O; Ryan A; Burnell M; Karpinskyj C; Gunu R; Kalsi JK; Dawnay A; Marino IP; Manchanda R; Lu K; Yang WL; Timms JF; Parmar M; Skates SJ; Bast RC; Jacobs IJ; Zaikin A; Menon U
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation.
    Kaaks R; Fortner RT; Hüsing A; Barrdahl M; Hopper M; Johnson T; Tjønneland A; Hansen L; Overvad K; Fournier A; Boutron-Ruault MC; Kvaskoff M; Dossus L; Johansson M; Boeing H; Trichopoulou A; Benetou V; La Vecchia C; Sieri S; Mattiello A; Palli D; Tumino R; Matullo G; Onland-Moret NC; Gram IT; Weiderpass E; Sánchez MJ; Navarro Sanchez C; Duell EJ; Ardanaz E; Larranaga N; Lundin E; Idahl A; Jirström K; Nodin B; Travis RC; Riboli E; Merritt M; Aune D; Terry K; Cramer DW; Anderson KS
    Int J Cancer; 2018 Aug; 143(3):515-526. PubMed ID: 29473162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
    Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
    Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.
    Cai G; Huang F; Gao Y; Li X; Chi J; Xie J; Zhou L; Feng Y; Huang H; Deng T; Zhou Y; Zhang C; Luo X; Xie X; Gao Q; Zhen X; Liu J
    Lancet Digit Health; 2024 Mar; 6(3):e176-e186. PubMed ID: 38212232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved early detection of ovarian cancer using longitudinal multimarker models.
    Whitwell HJ; Worthington J; Blyuss O; Gentry-Maharaj A; Ryan A; Gunu R; Kalsi J; Menon U; Jacobs I; Zaikin A; Timms JF
    Br J Cancer; 2020 Mar; 122(6):847-856. PubMed ID: 31937926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum expression of tumor marker CA242 in patients with different gynecological diseases.
    Zhu J; Li H
    Lab Med; 2023 Nov; 54(6):613-617. PubMed ID: 37035887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood collection conditions on ovarian cancer serum markers.
    Thorpe JD; Duan X; Forrest R; Lowe K; Brown L; Segal E; Nelson B; Anderson GL; McIntosh M; Urban N
    PLoS One; 2007 Dec; 2(12):e1281. PubMed ID: 18060075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.